LinkedIn Profile

Access GERO historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:gero-2 4994380 May 25th, 2019 12:00AM Gero 286 47.00 Open Biotechnology May 25th, 2019 08:03AM May 25th, 2019 08:03AM Gero is a longevity biotech company founded by a team of scientists and entrepreneurs with extensive experience in the area of life sciences. Our goal is to extend healthy lifespan and delay age-related health issues. We identify novel anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models. Open aging, longevity, target identification, marker identification, drug development, drug discovery, mHealth, Digital Health, Biological Age Open Paya Lebar Road 60, # 05-40B Paya Lebar Square Сингапур Singapore SG 409051 GERO Pharmaceuticals & Biotechnology
private:gero-2 4994380 Mar 18th, 2018 12:00AM Gero 196 39.00 Open Biotechnology Mar 18th, 2018 02:54PM Mar 18th, 2018 02:54PM Open GERO Pharmaceuticals & Biotechnology
private:gero-2 4994380 Feb 17th, 2018 12:00AM Gero 177 41.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM GERO is a drug discovery company creating first in class small molecule therapeutics using proprietary, industry-leading molecular modeling methods and systems in the sphere of biology technologies. Recently, we have shifted our focus to the development of new treatments to combat the aging process and extend healthy human lifespans. We have developed new insights in aging biology, primarily around the topic of stability and stress resistance of certain gene regulatory networks. Our research has revealed new targets, which in our opinion, will translate into innovative medical treatments that will delay a number of age-related diseases, including human frailty and mortality itself. By combining our powerful molecular modeling capabilities with our insights of the new drug targets, we are establishing a portfolio of new medicines to delay human mortality while still maintaining a high quality of life. Our latest publication http://www.nature.com/articles/srep13589 GERO Pharmaceuticals & Biotechnology
private:gero-2 4994380 Feb 16th, 2018 12:00AM Gero 177 41.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM GERO is a drug discovery company creating first in class small molecule therapeutics using proprietary, industry-leading molecular modeling methods and systems in the sphere of biology technologies. Recently, we have shifted our focus to the development of new treatments to combat the aging process and extend healthy human lifespans. We have developed new insights in aging biology, primarily around the topic of stability and stress resistance of certain gene regulatory networks. Our research has revealed new targets, which in our opinion, will translate into innovative medical treatments that will delay a number of age-related diseases, including human frailty and mortality itself. By combining our powerful molecular modeling capabilities with our insights of the new drug targets, we are establishing a portfolio of new medicines to delay human mortality while still maintaining a high quality of life. Our latest publication http://www.nature.com/articles/srep13589 GERO Pharmaceuticals & Biotechnology
private:gero-2 4994380 Feb 15th, 2018 12:00AM Gero 177 41.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM GERO is a drug discovery company creating first in class small molecule therapeutics using proprietary, industry-leading molecular modeling methods and systems in the sphere of biology technologies. Recently, we have shifted our focus to the development of new treatments to combat the aging process and extend healthy human lifespans. We have developed new insights in aging biology, primarily around the topic of stability and stress resistance of certain gene regulatory networks. Our research has revealed new targets, which in our opinion, will translate into innovative medical treatments that will delay a number of age-related diseases, including human frailty and mortality itself. By combining our powerful molecular modeling capabilities with our insights of the new drug targets, we are establishing a portfolio of new medicines to delay human mortality while still maintaining a high quality of life. Our latest publication http://www.nature.com/articles/srep13589 GERO Pharmaceuticals & Biotechnology
private:gero-2 4994380 Feb 14th, 2018 12:00AM Gero 177 41.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM GERO is a drug discovery company creating first in class small molecule therapeutics using proprietary, industry-leading molecular modeling methods and systems in the sphere of biology technologies. Recently, we have shifted our focus to the development of new treatments to combat the aging process and extend healthy human lifespans. We have developed new insights in aging biology, primarily around the topic of stability and stress resistance of certain gene regulatory networks. Our research has revealed new targets, which in our opinion, will translate into innovative medical treatments that will delay a number of age-related diseases, including human frailty and mortality itself. By combining our powerful molecular modeling capabilities with our insights of the new drug targets, we are establishing a portfolio of new medicines to delay human mortality while still maintaining a high quality of life. Our latest publication http://www.nature.com/articles/srep13589 GERO Pharmaceuticals & Biotechnology
private:gero-2 4994380 Feb 13th, 2018 12:00AM Gero 177 41.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM GERO is a drug discovery company creating first in class small molecule therapeutics using proprietary, industry-leading molecular modeling methods and systems in the sphere of biology technologies. Recently, we have shifted our focus to the development of new treatments to combat the aging process and extend healthy human lifespans. We have developed new insights in aging biology, primarily around the topic of stability and stress resistance of certain gene regulatory networks. Our research has revealed new targets, which in our opinion, will translate into innovative medical treatments that will delay a number of age-related diseases, including human frailty and mortality itself. By combining our powerful molecular modeling capabilities with our insights of the new drug targets, we are establishing a portfolio of new medicines to delay human mortality while still maintaining a high quality of life. Our latest publication http://www.nature.com/articles/srep13589 GERO Pharmaceuticals & Biotechnology
private:gero-2 4994380 Feb 12th, 2018 12:00AM Gero 177 41.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM GERO is a drug discovery company creating first in class small molecule therapeutics using proprietary, industry-leading molecular modeling methods and systems in the sphere of biology technologies. Recently, we have shifted our focus to the development of new treatments to combat the aging process and extend healthy human lifespans. We have developed new insights in aging biology, primarily around the topic of stability and stress resistance of certain gene regulatory networks. Our research has revealed new targets, which in our opinion, will translate into innovative medical treatments that will delay a number of age-related diseases, including human frailty and mortality itself. By combining our powerful molecular modeling capabilities with our insights of the new drug targets, we are establishing a portfolio of new medicines to delay human mortality while still maintaining a high quality of life. Our latest publication http://www.nature.com/articles/srep13589 GERO Pharmaceuticals & Biotechnology
private:gero-2 4994380 Feb 11th, 2018 12:00AM Gero 177 41.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM GERO is a drug discovery company creating first in class small molecule therapeutics using proprietary, industry-leading molecular modeling methods and systems in the sphere of biology technologies. Recently, we have shifted our focus to the development of new treatments to combat the aging process and extend healthy human lifespans. We have developed new insights in aging biology, primarily around the topic of stability and stress resistance of certain gene regulatory networks. Our research has revealed new targets, which in our opinion, will translate into innovative medical treatments that will delay a number of age-related diseases, including human frailty and mortality itself. By combining our powerful molecular modeling capabilities with our insights of the new drug targets, we are establishing a portfolio of new medicines to delay human mortality while still maintaining a high quality of life. Our latest publication http://www.nature.com/articles/srep13589 GERO Pharmaceuticals & Biotechnology
private:gero-2 4994380 Feb 10th, 2018 12:00AM Gero 177 41.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM GERO is a drug discovery company creating first in class small molecule therapeutics using proprietary, industry-leading molecular modeling methods and systems in the sphere of biology technologies. Recently, we have shifted our focus to the development of new treatments to combat the aging process and extend healthy human lifespans. We have developed new insights in aging biology, primarily around the topic of stability and stress resistance of certain gene regulatory networks. Our research has revealed new targets, which in our opinion, will translate into innovative medical treatments that will delay a number of age-related diseases, including human frailty and mortality itself. By combining our powerful molecular modeling capabilities with our insights of the new drug targets, we are establishing a portfolio of new medicines to delay human mortality while still maintaining a high quality of life. Our latest publication http://www.nature.com/articles/srep13589 GERO Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.